Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
about
Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy.Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene.Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse.Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.Pharmacokinetic Profiling of Conjugated Therapeutic Oligonucleotides: A High-Throughput Method Based Upon Serial Blood Microsampling Coupled to Peptide Nucleic Acid Hybridization Assay.Leveraging Physiology for Precision Drug Delivery
P2860
Q30275229-81F4CBD7-0565-4AA1-9A8A-1987E79BC63EQ37718210-43201307-79D0-4CB3-A4B0-45CA6354891FQ38663657-931255F3-672A-43E2-9301-CF1B9E717089Q47151105-CCC0FF88-A1B4-4805-8405-679EEE90492FQ47729841-6B381513-1BFC-407C-AEB0-1627D0103EEBQ47815341-2AD43D1C-3FAD-4780-87B4-35CAD57DA5EAQ57428850-2C3D2C90-DE07-4891-9DDD-1EFF1C3F9672
P2860
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
@en
type
label
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
@en
prefLabel
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
@en
P2093
P2860
P1476
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
@en
P2093
P2860
P304
P356
10.1016/J.ADDR.2015.12.004
P407
P577
2015-12-10T00:00:00Z